Aivis
Healthcare Software · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
238 Teheran-ro Fl 8, Seoul, Gangnam-gu, ...Phone Number
+61 263782021Website
www.aivis.krRevenue
$17 MillionIndustry
About Aivis
Aivis Org Chart
Is Aivis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Aivis launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aivis, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Aivis is spiking on competitors!
Check if Aivis has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aivis recently announced quarterly report
Funding: Get notified immidiatlly once Aivis has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Aivis had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aivis
Recommended Actions
Find VP level buyers at Aivis
Find 3 more new buyers
Company Profile Activity
Activity Insights
Aivis is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Aivis is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Aivis.
Aivis Tech Stack
A closer look at the technologies used by Aivis
Most Recent Scoops
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aivis
AIVIS specializes in AI-powered pathology solutions, providing advanced tools such as Qanti IHC and Qanti Ki-67 Micro for precise cancer diagnostics and personalized medicine. Their innovative products focus on smart quantification techniques to enhance accuracy in pathology. AIVIS aims to serve healthcare professionals and researchers in the field... Read More